DBT

DBT (DBT) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 13,150 VND, little changed on the session, giving a market capitalization of 274.6 billion VND.

On valuation, DBT trades at a price-to-earnings ratio of 10.0 and a price-to-book of 1.0. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 9.8% points to modest profitability relative to the company's equity base, below the sector average of 11.3%. Trailing earnings per share stand at 1,325 VND.

Aveluro tracks 9 news items mentioning DBT. The most recent catalyst was a leadership change event — "Bepharco (DBT) Names Tran Ngo Minh Anh CEO as Board Reshuffles". Aveluro's composite model rates DBT 7.8/10 (Bullish), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Recent developments around DBT include 5 notable classified events. On Oct 24, 2026, a leadership change was reported: Bepharco (DBT) appoints Tran Ngo Minh Anh, a 2002-born director and daughter of Nam A Bank chairman Tran Ngo Phuc Vu, as CEO from November 1, 2026, replacing Nguyen Khac Hanh after just over three months. On Oct 24, 2026, a leadership change was reported: Ben Tre Pharmaceutical (DBT) has named Tran Ngo Minh Anh, 24, as CEO and legal representative from early November, replacing Nguyen Khac Hanh, just three months after she joined the board as deputy CEO. On Oct 24, 2026, a leadership change was reported: Bepharco (DBT) has appointed Tran Ngo Minh Anh, born in 2002, as CEO effective 1 November 2026, roughly three months after she joined the board and became deputy CEO. On Oct 24, 2026, a leadership change was reported: Bepharco (DBT) has appointed Tran Ngo Minh Anh, a 24-year-old finance graduate and daughter of Nam A Bank chairman Tran Ngo Phuc Vu, as CEO effective 1 November 2026. On Oct 23, 2026, a leadership change was reported: Bepharco (DBT) has appointed Tran Ngo Minh Anh, 24, as CEO effective November 1, 2026, elevating her from a deputy CEO and board seat she took in August 2026.

Recent coverage shows a mixed sentiment balance across events.